Atossa Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATOS and other ETFs, options, and stocks.

About ATOS

Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. 

CEO
Steven C. Quay
CEOSteven C. Quay
Employees
14
Employees14
Headquarters
Seattle, Washington
HeadquartersSeattle, Washington
Founded
2008
Founded2008
Employees
14
Employees14

ATOS Key Statistics

Market cap
40.99M
Market cap40.99M
Price-Earnings ratio
-1.08
Price-Earnings ratio-1.08
Dividend yield
Dividend yield
Average volume
46.84K
Average volume46.84K
High today
$4.79
High today$4.79
Low today
$4.65
Low today$4.65
Open price
$4.67
Open price$4.67
Volume
28.64K
Volume28.64K
52 Week high
$19.35
52 Week high$19.35
52 Week low
$3.76
52 Week low$3.76

Stock Snapshot

As of today, Atossa Therapeutics(ATOS) shares are valued at $4.76. The company's market cap stands at 40.99M, with a P/E ratio of -1.08.

During the trading session on 2026-06-04, Atossa Therapeutics(ATOS) shares reached a daily high of $4.79 and a low of $4.65. At a current price of $4.76, the stock is +2.4% higher than the low and still -0.6% under the high.

Trading activity shows a volume of 28.64K, compared to an average daily volume of 46.84K.

Over the past 52 weeks, Atossa Therapeutics(ATOS) stock has traded between a high of $19.35 and a low of $3.76.

Over the past 52 weeks, Atossa Therapeutics(ATOS) stock has traded between a high of $19.35 and a low of $3.76.

ATOS News

TipRanks 7d
Jason McCarthy Reiterates Buy on Endoxifen Developer, Lifting 12-Month Price Target to $20 on Strong ER+ Breast Cancer Data and Pipeline Expansion - TipRanks

...

Jason McCarthy Reiterates Buy on Endoxifen Developer, Lifting 12-Month Price Target to $20 on Strong ER+ Breast Cancer Data and Pipeline Expansion - TipRanks

People also own

Based on the portfolios of people who own ATOS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.